# Antifungal Prophylaxis in Pediatric Acute Leukemia

> **NCT00624143** · PHASE3 · UNKNOWN · sponsor: **All India Institute of Medical Sciences** · enrollment: 100 (estimated)

## Conditions studied

- Pediatric Acute Leukemia Induction

## Interventions

- **DRUG:** ORAL VORICONAZOLE and IV Amphotericin B

## Key facts

- **NCT ID:** NCT00624143
- **Lead sponsor:** All India Institute of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-02
- **Primary completion:** 2009-12
- **Final completion:** —
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2008-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00624143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00624143, "Antifungal Prophylaxis in Pediatric Acute Leukemia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00624143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*